If you've been prescribed Imdevimab or are considering it, we'll walk you through what you need to know about this specialty medication.
About imdevimab
Imdevimab is an investigational monoclonal antibody therapy authorized for emergency use by the FDA to treat COVID-19. It must be administered together with casirivimanb. It is not yet FDA approved, and the safety and effectiveness of this therapy is still being evaluated.